Publication | Closed Access

Melphalan 200 mg/m2 in patients with renal impairment is associated with increased short-term toxicity but improved response and longer treatment-free survival

UrologyRenal FunctionMelphalan 200Longer Treatment-free SurvivalMedicineKidney FailurePharmacologyPharmacotherapyAcute Kidney InjuryChronic Kidney DiseaseNephrologyRenal Impairment